# Breast cancer research and treatment

Source: https://onco.cc/journals/breast-cancer-research-and-treatment/  
OnCo record `breast-cancer-research-and-treatment` (Journal). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Breast Cancer Research and Treatment is a long-established Springer journal spanning breast cancer biology, epidemiology and clinical management, read by breast oncologists and researchers.

## Summary

Breast Cancer Research and Treatment has been published since 1981, first by Kluwer Academic in Dordrecht, the Netherlands, and now by Springer, which Crossref lists as the publisher. As its title indicates, it spans both breast cancer research and treatment, and it is one of the longest-running journals devoted to the disease. The NLM record lists it as a Netherlands serial that is indexed in MEDLINE; it is not listed in DOAJ.

## Fields

- Kind: Journal
- Last checked: 2026-09-10
- Also known as: Breast Cancer Research and Treatment; Breast Cancer Res Treat
- Publisher: Springer
- Scope: breast cancer

## Sources

- Homepage: https://link.springer.com/journal/10549
- NLM Catalog: https://www.ncbi.nlm.nih.gov/nlmcatalog/8111104

## Connected records

- collections: [PubMed & Europe PMC](https://onco.cc/collections/pubmed-europepmc/)
- cancers: [Ductal carcinoma in situ (DCIS)](https://onco.cc/cancers/ductal-carcinoma-in-situ/), [HER2-positive breast cancer](https://onco.cc/cancers/breast-her2-positive/), [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Male breast cancer](https://onco.cc/cancers/male-breast-cancer/), [Triple-negative breast cancer (TNBC)](https://onco.cc/cancers/tnbc/)
- key papers: [A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas](https://onco.cc/key-papers/paper-donenberg-bahamas-brca1-founder-bcrt-2011/), [Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing](https://onco.cc/key-papers/paper-sharma-tnbc-registry-germline-brca-bcrt-2014/), [Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up](https://onco.cc/key-papers/paper-paloma-2-breast-cancer-res-treat-2019-update/), [The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer](https://onco.cc/key-papers/paper-villarreal-garza-mexican-tnbc-brca-bcrt-2015/)
- people: [Andrew Wardley](https://onco.cc/people/andrew-wardley/), [Dorraya El-Ashry](https://onco.cc/people/dorraya-el-ashry/), [Lori J. Pierce](https://onco.cc/people/lori-pierce/), [Rebecca Dent](https://onco.cc/people/rebecca-dent/), [Satu Tiainen](https://onco.cc/people/satu-tiainen/), [Shinji Ohno](https://onco.cc/people/ohno-shinji/)

---
JSON: https://onco.cc/api/v1/entities/breast-cancer-research-and-treatment.json